PXS
Pharmaxis
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 12 July 2023
- Reported shorts
- 1
- Shares on issue
- 719.659M
Pharmaxis (PXS) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for PXS (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- Half Year Report and Appendix 4DHalf Year Results26 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jan 2026via asx_announcements
- Quarterly Shareholder Report and Appendix 4CQuarterly Report28 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report28 Aug 2025via asx_announcements
- Preliminary Final ReportAnnual Results28 Aug 2025via asx_announcements
- Appendix 4C quarterly webinarQuarterly Report1 Aug 2025via asx_announcements
- Quarterly Appendix 4C Cash Flow ReportQuarterly Report1 Aug 2025via asx_announcements
- Quarterly Activities ReportQuarterly Report30 Apr 2025via asx_announcements
- Appendix 4C quarterly webinarQuarterly Report30 Apr 2025via asx_announcements
Showing 10 of 140 reports